The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study
NCT06747299
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
T-NK Cell Lymphoma
Sponsor
Ruijin Hospital
Collaborators
[object Object]